berbamine has been researched along with cyclin d1 in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 2 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Liang, Y; Qiu, X; Xu, RZ; Zhao, XY | 1 |
Horne, DA; Jove, R; Liu, L; Nam, S; Tian, Y; Yang, F; Zhao, R | 1 |
2 other study(ies) available for berbamine and cyclin d1
Article | Year |
---|---|
Berbamine inhibits proliferation and induces apoptosis of KU812 cells by increasing Smad3 activity.
Topics: Apoptosis; Benzylisoquinolines; Cell Line, Tumor; Cell Proliferation; Cyclin D1; Cyclin-Dependent Kinase Inhibitor p21; G1 Phase; Gene Expression Regulation; Humans; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Receptors, Transforming Growth Factor beta; Smad3 Protein | 2011 |
A novel synthetic derivative of the natural product berbamine inhibits cell viability and induces apoptosis of human osteosarcoma cells, associated with activation of JNK/AP-1 signaling.
Topics: Antineoplastic Agents; Apoptosis; Benzylisoquinolines; Bone Neoplasms; Caspase 3; Cell Line, Tumor; Cell Survival; Cyclin D1; Cyclin D2; Humans; JNK Mitogen-Activated Protein Kinases; Osteosarcoma; Phosphorylation; Reactive Oxygen Species; Signal Transduction; Transcription Factor AP-1 | 2013 |